Al-Omoush Omar, AlBarakat Majd M, Alasmar Deya'a, Al-Khalaileh Ali, Alzoubi Ahmad, Tarakhan Husam, Shakhatreh Zaid, Hatamleh Zaid, Abu-Saleh Mohammed, Saleh Othman, Altiti Abdalrahman, A Hazaymeh Wafa', Alshwayyat Sakhr, Hanifa Hamdah, Hazaimeh Ethar
Internal Medicine and Family Medicine Department, The Hashemite University, Zarqa, 13133, Jordan.
Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan.
BMC Neurol. 2025 May 26;25(1):225. doi: 10.1186/s12883-025-04250-0.
Neuro-Behçet's Disease (NBD) is a serious neurological complication of Behçet's Disease, but there's still a lack of research on its early-stage symptoms and imaging findings. While previous research highlights MRI abnormalities and cerebrospinal fluid changes, there hasn't been a systematic effort to identify patterns specific to newly diagnosed patients. Our study aimed to investigate the clinical and imaging characteristics of newly diagnosed parenchymal and non-parenchymal NBD based on case reports and case series studies.
We synthesized case reports and case series from MEDLINE, Scopus, EMBASE, PubMed, Web of Science, and Cochrane Library until October 17th,2023. Multiple statistical tests, such as the chi-square and Mann-Whitney tests, were used, with the corresponding 95% confidence interval (CI). The study protocol was registered with PROSPERO (ID: CRD42023472436). We included case reports and case series of adult patients (≥ 18 years) with a confirmed diagnosis of parenchymal or non-parenchymal Neuro-Behçet's disease (NBD), based on neurological symptoms attributed to Behçet's disease. Studies were required to report MRI findings demonstrating central or peripheral nervous system involvement.
Our analysis of 107 case reports and a case series (n = 174 patients) revealed that parenchymal NBD patients (n = 141; mean age 35.54 ± 13.33 years) frequently presented with ocular manifestations (80.9%), pyramidal signs (57.5%), cranial nerve palsies (50.4%), and headache (32.6%) while non-parenchymal NBD patients (n = 19; mean age 28.68 ± 10.67 years) commonly experienced headache (86.4%), papilledema (47.4%), cranial nerve palsies (42.1%), and nausea (31.6%). For the mixed-type group (n = 14; mean age 27.5 ± 11.57 years), commonly presented with headache (64.3%), pyramidal sign (50%), fever (50%), and diplopia (35.7%). Brainstem involvement for parenchymal NBD predominated in acute and chronic cases. Contrast enhancement was significantly more prevalent in acute NBD compared to chronic progressive NBD.
Neuro-Behçet's disease is an uncommon but serious medical condition with varying symptoms based on its type. Parenchymal and non-parenchymal NBD have unique patterns, with parenchymal cases exhibiting primarily ocular symptoms and pyramidal signs, while non-parenchymal cases present with headache and papilledema. Patients with both types of features were more likely to experience headaches, pyramidal symptoms, fever, and diplopia. Recognizing these patterns can help diagnose and treat the disease earlier.
神经白塞病(Neuro-Behçet's Disease,NBD)是白塞病的一种严重神经并发症,但目前对其早期症状和影像学表现仍缺乏研究。尽管先前的研究强调了MRI异常和脑脊液变化,但尚未有系统的努力来识别新诊断患者特有的模式。我们的研究旨在基于病例报告和病例系列研究,探讨新诊断的实质性和非实质性NBD的临床和影像学特征。
我们综合了截至2023年10月17日来自MEDLINE、Scopus、EMBASE、PubMed、Web of Science和Cochrane图书馆的病例报告和病例系列。使用了多种统计检验,如卡方检验和曼-惠特尼检验,并给出相应的95%置信区间(CI)。该研究方案已在PROSPERO注册(ID:CRD42023472436)。我们纳入了基于归因于白塞病的神经症状确诊为实质性或非实质性神经白塞病(NBD)的成年患者(≥18岁)的病例报告和病例系列。研究需报告显示中枢或周围神经系统受累的MRI结果。
我们对107例病例报告和1个病例系列(n = 174例患者)的分析显示,实质性NBD患者(n = 141;平均年龄35.54±13.33岁)常出现眼部表现(80.9%)、锥体束征(57.5%)、颅神经麻痹(50.4%)和头痛(32.6%),而非实质性NBD患者(n = 19;平均年龄28.68±10.67岁)常出现头痛(86.4%)、视乳头水肿(47.4%)、颅神经麻痹(42.1%)和恶心(31.6%)。混合型组(n = 14;平均年龄27.5±11.57岁)常出现头痛(64.3%)、锥体束征(50%)、发热(50%)和复视(35.7%)。实质性NBD的脑干受累在急性和慢性病例中占主导。与慢性进行性NBD相比,急性NBD的对比增强明显更常见。
神经白塞病是一种罕见但严重的疾病,其症状因类型而异。实质性和非实质性NBD有独特的模式,实质性病例主要表现为眼部症状和锥体束征,而非实质性病例则表现为头痛和视乳头水肿。具有两种类型特征的患者更有可能出现头痛、锥体束症状、发热和复视。认识到这些模式有助于更早地诊断和治疗该疾病。